Note: Ingredients listed on restricted chemical lists
EC/CAS
103-90-2
Name of the chemical
N-(4-hydroxyphenyl) acetamide
Concentration
N/A
EC/CAS
99-76-3
Name of the chemical
4-Hydroxybenzoic acid and its Methyl- and Ethyl-esters, and their salts
Concentration
N/A
EC/CAS
57-50-1
Name of the chemical
Sucrose, pure C12H22O11
Concentration
N/A
EC/CAS
8004-92-0
Name of the chemical
1H-Indene-1,3(2H)-dione, 2-(2-quinolinyl)-, sulfonated, sodium salts (CI 47005) (35), (36)
Concentration
N/A
General Information
Revision date
2015-03-25
Product name
Zamicet (Hydrocodone Bitartrate and Acetaminophen Oral Solution)
Emergency telephone
800.424.9300
Icons in SDS
Company Information
company name
Beach Pharmaceuticals Division of Beach Products, Inc
Section 2
2.1 Classification of the substance or mixture
This product is a mixture and is a pharmaceutical product. It is considered non- Hazardous according to the OSHA Hazard Communication Standard 2012 (29 CFR 1910.1200). Chemical family: Mixture
Hazard statements
May be harmful if swallowed.
Additional information
Short term: Acetaminophen has been associated with cases of acute liver failure resulting in liver transplant and death. Most of the cases of liver injury are associated with the use of acetaminophen at doses that exceed 4000 milligrams per day, and often involve more than one acetaminophen containing product. Hydrocodone may cause lightheadedness, sedation, dizziness, pinpoint pupils, nausea and vomiting. Other side effects include constipation, rash and itching. Long term: May be habit forming. 00 Known Clinical Effects: Therapeutic use of this substance has resulted in liver failure, serious skin reactions such as acute generalized exanthematous pustulosis, Stevens- Johnson syndrome and toxic epidermal necrolysis. Ingestion of this material may cause effects similar to those seen in clinical use including dry mouth, drowsiness, headache, dizziness, nausea, vomiting, weakness, anxiety, blurred vision and dilated pupils. Cases of overdosage may also lead to respiratory depression, hypotension, coma, convulsions, cardiac arrhythmia, and tachycardia. Additionally, symptoms of dependence / withdrawal may occur. EU Indication of danger: Not classified. Emergency overview Seek medical attention in case of accidental exposure or overdose. The product is generally safe when used as prescribed. Note: This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the active substance or its intermediates regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential of exposure in your workplace.
Precautionary statements
General advice: Seek medical attention in case of accidental exposure or overdose. Eyes: Avoid contact with eyes. Skin Contact: Avoid skin contact. Inhalation: Not intended for inhalation. Ingestion: Generally safe at recommended doses. In case of overdose, seek medical attention immediately.
Storage
There are no special storage conditions for safety. For product integrity, store under conditions specified on the label.
Disposal
Dispose of in accordance with applicable laws and regulations. 00